Davis Polk advised the underwriters in the offering. Editas Medicine, Inc. executed its $231 million common stock offering of 3,500,000 shares of common stock. The common…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
